Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to
assemble and peer-review its pathway modules. The integration of ORCID within Reactome
enables us to meet a key challenge with authoring, curating and reviewing biological
information by incentivizing and crediting the external experts that contribute their
expertise and time to the Reactome curation process. More information is available at
ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please
forward this information to us and we will update your Reactome pathway records.
Details on Person Comprehensive analysis of CDKN2A (p16INK4A/p14ARF) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanoma
| Class:Id | LiteratureReference:9634125 |
| _displayName | Comprehensive analysis of CDKN2A (p16INK4A/p14ARF) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanoma |
| _timestamp | 2019-01-04 22:53:34 |
| author | [Person:9634113] Laud, K [Person:9634088] Marian, C [Person:9634092] Avril, M F [Person:9634097] Barrois, M [Person:9634118] Chompret, A [Person:9634136] Goldstein, A M [Person:9634132] Tucker, M A [Person:9634096] Clark, P A [Person:3200030] Peters, G [Person:9634120] Chaudru, V [Person:9634127] Demenais, F [Person:9634115] Spatz, A [Person:5319414] Smith, M W [Person:9634117] Lenoir, G M [Person:9634109] Bressac-de Paillerets, B |
| created | [InstanceEdit:9634100] Orlic-Milacic, Marija, 2019-01-04 |
| journal | J. Med. Genet. |
| pages | 39-47 |
| pubMedIdentifier | 15937071 |
| title | Comprehensive analysis of CDKN2A (p16INK4A/p14ARF) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanoma |
| volume | 43 |
| year | 2006 |
| (literatureReference) | [Pathway:9630750] Evasion of Oncogene Induced Senescence Due to p16INK4A Defects [Homo sapiens] [Pathway:9632693] Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects [Homo sapiens] |
|
[Change default viewing format]
|
No pathways have been reviewed or authored by Comprehensive analysis of CDKN2A (p16INK4A/p14ARF) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanoma (9634125)